Drug Approval Package

Rescriptor (Delavirdine Mesylate) Tablets
Company: Agouron Pharmaceuticals, Inc.
Application No.:  020705s008
Approval Date: 05/16/2001

• Approval Letter(s) (PDF)  

• Printed Labeling (PDF)  

• Medical Review(s) (PDF)

• Chemistry Review(s) (PDF)  

• Pharmacology Review(s) (PDF)  

• Statistical Review(s) (PDF)  

• Microbiology Review(s) (PDF)  

• Clinical Pharmacology Biopharmaceutics Review(s) (PDF)  

• Administrative Document(s) & Correspondence (PDF)  

Date created:  July 09, 2007

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.